D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.
Gaieb, Z., Liu, S., Gathiaka, S., Chiu, M., Yang, H., Shao, C., Feher, V.A., Walters, W.P., Kuhn, B., Rudolph, M.G., Burley, S.K., Gilson, M.K., Amaro, R.E.(2018) J Comput Aided Mol Des 32: 1-20
- PubMed: 29204945 
- DOI: https://doi.org/10.1007/s10822-017-0088-4
- Primary Citation of Related Structures:  
5Q0I, 5Q0J, 5Q0K, 5Q0L, 5Q0M, 5Q0N, 5Q0O, 5Q0P, 5Q0Q, 5Q0R, 5Q0S, 5Q0T, 5Q0U, 5Q0V, 5Q0W, 5Q0X, 5Q0Y, 5Q0Z, 5Q10, 5Q11, 5Q12, 5Q13, 5Q14, 5Q15, 5Q16, 5Q17, 5Q18, 5Q19, 5Q1A, 5Q1B, 5Q1C, 5Q1D, 5Q1E, 5Q1F, 5Q1G, 5Q1H, 5Q1I - PubMed Abstract: 
The Drug Design Data Resource (D3R) ran Grand Challenge 2 (GC2) from September 2016 through February 2017. This challenge was based on a dataset of structures and affinities for the nuclear receptor farnesoid X receptor (FXR), contributed by F. Hoffmann-La Roche ...